Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

February 3, 2021 Research and Development COVID-19

The past week has seen mostly positive COVID-19 vaccine developments; Pfizer has confirmed its jab is effective against both the …
News
astrazeneca_sign_sky

Longer Oxford-AstraZeneca vaccine interval improves efficacy, report says

February 3, 2021 Research and Development AstraZeneca, COVID-19

A longer interval between doses of the Oxford University-AstraZeneca vaccine could substantially improve efficacy, according to a report published in …
News

GSK and CureVac sign £132m deal to develop next-generation COVID-19 vaccine

February 3, 2021 Research and Development COVID-19, CureVac, GlaxoSmithKline

GlaxoSmithKline (GSK) and CureVac have today announced they are joining forces to develop a new COVID-19 vaccine to combat future …
News
stock-incyte-01-shutter

CHMP recommends marketing authorisation for Incyte’s pemigatinib

February 3, 2021 Research and Development EMA, Incyte

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended the conditional marketing authorisation of Incyte’s pemigatinib for …
News

New urine test could detect womb cancer in three hours

February 3, 2021 Research and Development Cancer, urine test

A simple test using patented technology to detect the cancer biomarker MCM5 (Minichromosome Maintenance Complex Component 5) in urine could …
News
philippe_dro

Scenic Biotech appoints Dr Philippe Dro as Chairman

February 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Scenic Biotech has announced the appointment of Dr Philippe Dro as its independent Chairman. Dr Dro replaces Dr Ulrich Grau, …
Appointment
celgene_building

NICE recommends Celgene’s REVLIMID for multiple myeloma

January 27, 2021 Research and Development Cancer, Celgene

NICE has issued a Final Appraisal Document (FAD) recommending Celgene’s REVLIMID (lenalidomide) as maintenance treatment after an autologous stem cell …
News

Diurnal and Citrine sign licensing agreement for Alkindi

January 27, 2021 Research and Development Citrine, Diurnal

Diurnal Group has entered into an exclusive licence agreement for its product Alkindi (hydrocortisone granules in capsules for opening) with …
News
drug-trials

How COVID-19 has affected the oncology drugs market

January 25, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Cancer

In its disruption to clinical trials and drug supply to patients, the COVID-19 pandemic has impacted the most crucial areas …
Feature
nicki_grundy

Raremark appoints Nicki Grundy as CFO

January 20, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Raremark, a global healthtech company specialising in rare disease, has appointed Nicki Grundy as Chief Financial Officer. As a key …
Appointment
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

January 20, 2021 Research and Development

The past week has seen promising developments in the race to find treatments for COVID-19; Jubilant and The Wistar Institute …
News
stem_cell

Scientists in Scotland make breakthrough MND discovery

January 20, 2021 Research and Development motor neurone disease

Researchers in Scotland have made a discovery that could reverse the damage caused by motor neurone disease (MND). University of …
News

NICE approves lipid disorder drug Myalepta for NHS use

January 20, 2021 Research and Development Amryt Pharma, NICE

NICE has approved Amryt’s rare lipid disorder drug Myalepta (metreleptin), currently the only leptin replacement therapy available, for use within …
News
astrazeneca_sign_sky

EU approves breast cancer drug Enhertu

January 20, 2021 Research and Development AstraZeneca, Daiichi Sankyo

The EU has granted AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) conditional approval as a monotherapy for the treatment of …
News

Pfizer-BioNTech COVID-19 vaccine likely to protect against UK variant, study says

January 20, 2021 Research and Development COVID-19, Pfizer

The Pfizer-BioNTech COVID-19 vaccine is likely to protect against the coronavirus variant found in Britain, the latest research says. The …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025